Authors
DeSl
- GitHub: DeniseSl22
- ORCiD: 0000-0001-8449-1318
- Wikidata: Q43744369
- Glycolysis and gluconeogenesis - WP534 (Homo sapiens)
- Autophagy in pancreatic ductal adenocarcinoma - WP5331 (Homo sapiens)
- DYRK1A involvement regarding cell proliferation in brain development - WP5180 (Homo sapiens)
- Elongation of (very) long chain fatty acids - WP4491 (Mus musculus)
- Eicosanoid metabolism via lipoxygenases (LOX) - WP4348 (Mus musculus)
- Ether lipid biosynthesis - WP5275 (Homo sapiens)
- Fatty Acids and Lipoproteins Transport in Hepatocytes - WP5323 (Homo sapiens)
- Nuclear receptors meta-pathway - WP2882 (Homo sapiens)
- RAS and bradykinin pathways in COVID-19 - WP4969 (Homo sapiens)
- Glucocorticoid biosynthesis - WP5280 (Homo sapiens)
- Serotonin receptor 4/6/7 and NR3C signaling - WP734 (Homo sapiens)
- Serotonin receptor 2 and ELK-SRF/GATA4 signaling - WP732 (Homo sapiens)
- Serotonin HTR1 group and FOS pathway - WP722 (Homo sapiens)
- Cholesterol metabolism - WP5333 (Homo sapiens)
- Primary ovarian insufficiency - WP5316 (Homo sapiens)
- IL-10 anti-inflammatory signaling pathway - WP4495 (Homo sapiens)
- Serotonin transporter activity - WP3138 (Bos taurus)
- Codeine and morphine metabolism - WP1604 (Homo sapiens)
- Cysteine biosynthesis from homoserine - WP256 (Saccharomyces cerevisiae)
- GPCRs, class A rhodopsin-like - WP473 (Rattus norvegicus)
- Sucrose biosynthesis - WP14 (Saccharomyces cerevisiae)
- Colanic acid building blocks biosynthesis - WP121 (Saccharomyces cerevisiae)
- Mineralocorticoid biosynthesis - WP5279 (Homo sapiens)
- Steroid hormone precursor biosynthesis - WP5277 (Homo sapiens)
- Oxysterols derived from cholesterol - WP4545 (Homo sapiens)
- Classical pathway of steroidogenesis with glucocorticoid and mineralocorticoid metabolism - WP4523 (Homo sapiens)
- Amino acid transport defects (IEMs) - WP5029 (Homo sapiens)
- Disorders in ketolysis - WP5195 (Homo sapiens)
- Retinol metabolism - WP5188 (Homo sapiens)
- Type I interferon induction and signaling during SARS-CoV-2 infection - WP4868 (Homo sapiens)
- Fatty acid biosynthesis - WP568 (Drosophila melanogaster)
- Fatty acid biosynthesis - WP38 (Caenorhabditis elegans)
- Fatty acid biosynthesis - WP357 (Homo sapiens)
- Glycerophospholipid biosynthetic pathway - WP3198 (Bos taurus)
- Complement system - WP2806 (Homo sapiens)
- Glycerol teichoic acid biosynthesis - WP563 (Saccharomyces cerevisiae)
- PtdIns(4,5)P2 in cytokinesis pathway - WP5199 (Homo sapiens)
- Resolvin E1 and resolvin D1 signaling pathways promoting inflammation resolution - WP5191 (Homo sapiens)
- Disorders in ketone body synthesis - WP5175 (Homo sapiens)
- Disorders of galactose metabolism - WP5173 (Homo sapiens)
- Leukotriene metabolic pathway - WP5171 (Homo sapiens)
- Oxidative stress and redox pathway - WP4466 (Mus musculus)
- Non-homologous end joining - WP438 (Homo sapiens)
- Flavan-3-ol metabolic pathway - WP4238 (Homo sapiens)
- Metabolism of tetrahydrocannabinol (THC) - WP4174 (Homo sapiens)
- Poly(glycerol phosphate) wall teichoic acid biosynthesis - WP4162 (Saccharomyces cerevisiae)
- Prader-Willi and Angelman syndrome - WP3998 (Homo sapiens)
- SK UDPglcnac - WP3641 (Escherichia coli)
- Evolocumab mechanism to reduce LDL cholesterol - WP3408 (Homo sapiens)
- Pentose phosphate pathway - WP282 (Rattus norvegicus)
- Primary focal segmental glomerulosclerosis (FSGS) - WP2573 (Mus musculus)
- Purine metabolism - WP2185 (Mus musculus)
- DNA replication - WP192 (Caenorhabditis elegans)
- Translation factors - WP110 (Caenorhabditis elegans)
- mRNA processing - WP123 (Caenorhabditis elegans)
- Cholesterol metabolism with Bloch and Kandutsch-Russell pathways - WP4346 (Mus musculus)
- Vitamin A and carotenoid metabolism - WP716 (Homo sapiens)
- Aflatoxin B1 metabolism - WP699 (Homo sapiens)
- Heme biosynthesis - WP561 (Homo sapiens)
- Roles of ceramides in development of insulin resistance - WP5181 (Homo sapiens)
- Deregulation of renin-angiotensin system by SARS-CoV infection - WP4965 (Mus musculus)
- 1q21.1 copy number variation syndrome - WP4905 (Homo sapiens)
- TCA cycle - WP490 (Saccharomyces cerevisiae)
- Purine metabolism - WP4792 (Homo sapiens)
- Sphingolipid metabolism: integrated pathway - WP4726 (Homo sapiens)
- Sphingolipid metabolism overview - WP4725 (Homo sapiens)
- Omega-9 fatty acid synthesis - WP4724 (Homo sapiens)
- Omega-3 / omega-6 fatty acid synthesis - WP4723 (Homo sapiens)
- Glycerolipids and glycerophospholipids - WP4722 (Homo sapiens)
- Eicosanoid metabolism via lipooxygenases (LOX) - WP4721 (Homo sapiens)
- Eicosanoid metabolism via cytochrome P450 monooxygenases pathway - WP4720 (Homo sapiens)
- Eicosanoid metabolism via cyclooxygenases (COX) - WP4719 (Homo sapiens)
- Cholesterol metabolism with Bloch and Kandutsch-Russell pathways - WP4718 (Homo sapiens)
- Sphingolipid metabolism (integrated pathway) - WP4690 (Mus musculus)
- Gamma-glutamyl cycle for the biosynthesis and degradation of glutathione, including diseases - WP4518 (Homo sapiens)
- Omega-9 fatty acid synthesis - WP4351 (Mus musculus)
- Omega-3 / omega-6 fatty acid synthesis - WP4350 (Mus musculus)
- Eicosanoid metabolism via cytochrome P450 monooxygenases - WP4349 (Mus musculus)
- Eicosanoid metabolism via cyclooxygenases (COX) - WP4347 (Mus musculus)
- Glycerolipids and glycerophospholipids - WP4345 (Mus musculus)
- Sphingolipid metabolism overview - WP4344 (Mus musculus)
- Methionine metabolism leading to sulfur amino acids and related disorders - WP4292 (Homo sapiens)
- Vitamin B6-dependent and responsive disorders - WP4228 (Homo sapiens)
- Pyrimidine metabolism and related diseases - WP4225 (Homo sapiens)
- Purine metabolism and related disorders - WP4224 (Homo sapiens)
- Neurotransmitter disorders - WP4220 (Homo sapiens)
- Biosynthesis and regeneration of tetrahydrobiopterin and catabolism of phenylalanine - WP4156 (Homo sapiens)
- Degradation pathway of sphingolipids, including diseases - WP4153 (Homo sapiens)
- VEGFA-VEGFR2 signaling - WP3888 (Homo sapiens)
- Brassinolide biosynthetic pathway - WP2634 (Arabidopsis thaliana)
- Glial cell differentiation - WP2276 (Homo sapiens)
- Heme biosynthesis - WP18 (Mus musculus)
- Eicosanoid synthesis - WP167 (Homo sapiens)
- Selenium micronutrient network - WP15 (Homo sapiens)
- Fatty acid beta-oxidation - WP143 (Homo sapiens)
- Sulfur amino acid biosynthesis - WP7 (Saccharomyces cerevisiae)
- Chronic hyperglycemia impairment of neuron function - WP5283 (Homo sapiens)
- Farnesyl to CoQ10 metabolism - WP5274 (Homo sapiens)
- Effect of intestinal microbiome on anticoagulant response of vitamin K antagonists - WP5273 (Homo sapiens)
- LDL- influence on CD14 and TLR4 - WP5272 (Homo sapiens)
- COVID-19 and endothelial cell senescence - WP5256 (Homo sapiens)
- Mitochondrial beta-oxidation - WP5241 (Homo sapiens)
- Phospholipid biosynthesis - WP5201 (Saccharomyces cerevisiae)
- Synthesis of ceramides and 1-deoxyceramides - WP5194 (Homo sapiens)
- Cholesterol synthesis disorders - WP5193 (Homo sapiens)
- Modulation of PI3K-Akt-mTOR signaling by bioactive sphingolipids - WP5192 (Homo sapiens)
- Creatine pathway - WP5190 (Homo sapiens)
- Vitamin K metabolism and activation of dependent proteins - WP5186 (Homo sapiens)
- Pro-survival signaling of neuroprotectin D1 - WP5182 (Homo sapiens)
- Biosynthesis and turnover of 1-deoxy-sphingoid bases - WP5179 (Homo sapiens)
- Leucine, isoleucine and valine metabolism - WP4686 (Homo sapiens)
- Peroxisomal beta-oxidation of tetracosanoyl-CoA - WP1941 (Homo sapiens)
- ACE inhibitor pathway - WP554 (Homo sapiens)
- Aryl hydrocarbon receptor pathway - WP2586 (Homo sapiens)
- COVID-19, thrombosis and anticoagulation - WP4927 (Homo sapiens)
- CAMKK2 pathway - WP4874 (Homo sapiens)
- Vitamin D in inflammatory diseases - WP4482 (Homo sapiens)
- Folate metabolism - WP176 (Homo sapiens)
- Vitamin B12 metabolism - WP1533 (Homo sapiens)
- Glyoxylate metabolism - WP5166 (Homo sapiens)
- Hemesynthesis defects and porphyrias - WP5169 (Homo sapiens)
- Copper metabolism - WP5189 (Homo sapiens)
- Disorders of bile acid synthesis and biliary transport - WP5176 (Homo sapiens)
- Linoleic acid metabolism affected by SARS-CoV-2 - WP4853 (Homo sapiens)
- Glycolysis and gluconeogenesis - WP1567 (Mycobacterium tuberculosis)
- Methionine de novo and salvage pathway - WP3580 (Homo sapiens)
- One-carbon metabolism - WP241 (Homo sapiens)
- Hair follicle development: cytodifferentiation - part 3 of 3 - WP2840 (Homo sapiens)
- Acetogenesis - WP5019 (Acetobacterium woodii)
- Pluripotent stem cell differentiation pathway - WP2848 (Homo sapiens)
- Spinal cord injury - WP2431 (Homo sapiens)
- Allograft rejection - WP2328 (Homo sapiens)
- Microglia pathogen phagocytosis pathway - WP3937 (Homo sapiens)
- Quercetin and Nf-kB / AP-1 induced apoptosis - WP2435 (Homo sapiens)
- Cell cycle - WP179 (Homo sapiens)
- Follicle stimulating hormone (FSH) signaling pathway - WP2035 (Homo sapiens)
- Thyroid stimulating hormone (TSH) signaling pathway - WP2032 (Homo sapiens)
- DNA IR-damage and cellular response via ATR - WP4016 (Homo sapiens)
- TGF-beta signaling pathway - WP366 (Homo sapiens)
- Wnt signaling pathway - WP363 (Homo sapiens)
- RANKL/RANK signaling pathway - WP2018 (Homo sapiens)
- Aryl hydrocarbon receptor pathway - WP2873 (Homo sapiens)
- Notch signaling pathway - WP61 (Homo sapiens)
- Ebola virus infection in host - WP4217 (Homo sapiens)
- Hedgehog signaling pathway - WP47 (Homo sapiens)
- Ferroptosis - WP4313 (Homo sapiens)
- Fluoropyrimidine activity - WP1601 (Homo sapiens)
- Cholesterol biosynthesis pathway - WP197 (Homo sapiens)
- 7-oxo-C and 7-beta-HC pathways - WP5064 (Homo sapiens)
- Riboflavin and CoQ disorders - WP5037 (Homo sapiens)
- Ethylmalonic encephalopathy - WP5030 (Homo sapiens)
- Serine metabolism - WP4688 (Homo sapiens)
- Urea cycle and associated pathways - WP4595 (Homo sapiens)
- Urea cycle and related diseases - WP4571 (Homo sapiens)
- Tyrosine metabolism and related disorders - WP4506 (Homo sapiens)
- Lamin A-processing pathway - WP4299 (Homo sapiens)
- Thiamine metabolic pathways - WP4297 (Homo sapiens)
- MTHFR deficiency - WP4288 (Homo sapiens)
- Vitamin B12 disorders - WP4271 (Homo sapiens)
- Krebs cycle disorders - WP4236 (Homo sapiens)
- GABA metabolism (aka GHB) - WP4157 (Homo sapiens)
- Cell differentiation - index - WP2029 (Homo sapiens)
- Pyrimidine metabolism - WP4022 (Homo sapiens)
- Focal adhesion: PI3K-Akt-mTOR-signaling pathway - WP3932 (Homo sapiens)
- Glycerophospholipid biosynthetic pathway - WP2533 (Homo sapiens)
- Statin inhibition of cholesterol production - WP430 (Homo sapiens)
- Beta-oxidation of unsaturated fatty acids - WP471 (Caenorhabditis elegans)
- Mevalonate arm of cholesterol biosynthesis pathway with inhibitors - WP4189 (Homo sapiens)
- Trehalose degradation, low osmolarity - WP70 (Saccharomyces cerevisiae)
- Cerebral organic acidurias, including diseases - WP4519 (Homo sapiens)
- Effect of L-carnitine on metabolism - WP3992 (Danio rerio)
- Cori cycle - WP1946 (Homo sapiens)
- Nicotine metabolism in liver cells - WP1600 (Homo sapiens)
- Tryptophan metabolism - WP465 (Homo sapiens)
- Aerobic glycolysis - WP4629 (Homo sapiens)
- Major receptors targeted by epinephrine and norepinephrine - WP4589 (Homo sapiens)
- Metabolism of alpha-linolenic acid - WP4586 (Homo sapiens)
- Biomarkers for pyrimidine metabolism disorders - WP4584 (Homo sapiens)
- Blood clotting and drug effects - WP4580 (Homo sapiens)
- Alternative pathway of fetal androgen synthesis - WP4524 (Homo sapiens)
- Metabolic pathway of LDL, HDL and TG, including diseases - WP4522 (Homo sapiens)
- Glycosylation and related congenital defects - WP4521 (Homo sapiens)
- Molybdenum cofactor (Moco) biosynthesis - WP4507 (Homo sapiens)
- Cysteine and methionine catabolism - WP4504 (Homo sapiens)
- Role of carnosine in muscle contraction - WP4486 (Homo sapiens)
- Modified nucleosides derived from tRNA as urinary cancer markers - WP4485 (Homo sapiens)
- Ras signaling - WP4223 (Homo sapiens)
- Hormonal control of pubertal growth spurt - WP4194 (Homo sapiens)
- GABA receptor signaling - WP4159 (Homo sapiens)
- Metabolism of sphingolipids in ER and Golgi apparatus - WP4142 (Homo sapiens)
- Toll-like receptor signaling pathway - WP75 (Homo sapiens)
- Complement and coagulation cascades - WP558 (Homo sapiens)
- Host-pathogen interaction of human coronaviruses - MAPK signaling - WP4877 (Homo sapiens)
- Rett syndrome causing genes - WP4312 (Homo sapiens)
- Oligodendrocyte specification and differentiation, leading to myelin components for CNS - WP4304 (Homo sapiens)
- Disorders of folate metabolism and transport - WP4259 (Homo sapiens)
- One-carbon metabolism and related pathways - WP3940 (Homo sapiens)
- Ketogenesis and ketolysis - WP4742 (Homo sapiens)
- Biotin metabolism, including IMDs - WP5031 (Homo sapiens)
- Glycogen synthesis and degradation - WP500 (Homo sapiens)
- Urea cycle and metabolism of amino groups - WP497 (Homo sapiens)
- Steroid biosynthesis - WP496 (Homo sapiens)
- MAPK signaling pathway - WP382 (Homo sapiens)
- TCA cycle (aka Krebs or citric acid cycle) - WP78 (Homo sapiens)
- Pathways of nucleic acid metabolism and innate immune sensing - WP4705 (Homo sapiens)
- Hypoxia-dependent differentiation of myoblasts - WP5025 (Mus musculus)
- Hepatocyte growth factor receptor signaling - WP94 (Rattus norvegicus)
- Hepatocyte growth factor receptor signaling - WP927 (Pan troglodytes)
- Hepatocyte growth factor receptor signaling - WP313 (Homo sapiens)
- Hepatocyte growth factor receptor signaling - WP1046 (Bos taurus)
- S1P receptor signal transduction - WP26 (Homo sapiens)
- Fatty acid beta-oxidation 3 - WP499 (Caenorhabditis elegans)
- Mitochondrial long chain fatty acid beta-oxidation - WP448 (Caenorhabditis elegans)
- Triacylglyceride synthesis - WP212 (Caenorhabditis elegans)
- BMP signaling pathway - WP211 (Danio rerio)
- Fatty acid beta-oxidation 2 - WP148 (Caenorhabditis elegans)
- Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway - WP4577 (Homo sapiens)
- Mevalonate arm of cholesterol biosynthesis pathway - WP4190 (Homo sapiens)
- ERK1-ERK2 MAPK cascade - WP402 (Danio rerio)
- Cannabinoid receptor signaling - WP3869 (Homo sapiens)
- Caffeine and theobromine metabolism - WP3633 (Homo sapiens)
- Flavonoid pathway - WP3620 (Arabidopsis thaliana)
- Sucrose metabolism - WP2623 (Arabidopsis thaliana)
- Pathogenic Escherichia coli infection - WP2272 (Homo sapiens)
- Vitamin D metabolism - WP1531 (Homo sapiens)
- FGF signaling pathway - WP152 (Danio rerio)
- Sphingolipid pathway - WP1422 (Homo sapiens)
- Pentose phosphate metabolism - WP134 (Homo sapiens)
- Fatty acid beta-oxidation 1 - WP126 (Caenorhabditis elegans)
- Left-right asymmetry in the nervous system - WP2229 (Caenorhabditis elegans)
- Regulation of Wnt / B-catenin signaling by small molecule compounds - WP3664 (Homo sapiens)
- Wnt signaling pathway and pluripotency - WP723 (Mus musculus)
- Pentose phosphate pathway - WP63 (Mus musculus)
- Mapk signaling pathway - WP493 (Mus musculus)
- Eicosanoid lipid synthesis map - WP4335 (Mus musculus)
- BMP signaling pathway in eyelid development - WP3663 (Mus musculus)
- Sulfation biotransformation reaction - WP692 (Homo sapiens)
- Catalytic cycle of mammalian flavin-containing monooxygenases (FMOs) - WP688 (Homo sapiens)
- DNA repair pathways, full network - WP4946 (Homo sapiens)
- Cholesterol biosynthesis with skeletal dysplasias - WP4804 (Homo sapiens)
- Head and neck squamous cell carcinoma - WP4674 (Homo sapiens)
- Amino acid metabolism pathway excerpt: histidine catabolism extension - WP4661 (Homo sapiens)
- Embryonic stem cell pluripotency pathways - WP3931 (Homo sapiens)
- Toll-like receptor signaling related to MyD88 - WP3858 (Homo sapiens)
- Cell-type dependent selectivity of CCK2R signaling - WP3679 (Homo sapiens)
- Tgif disruption of Shh signaling - WP3674 (Homo sapiens)
- Biochemical pathways: part I - WP3604 (Homo sapiens)
- Lipid particles composition - WP3601 (Homo sapiens)
- Circadian rhythm genes - WP3594 (Homo sapiens)
- Hair follicle development: organogenesis - part 2 of 3 - WP2839 (Homo sapiens)
- Sulindac metabolic pathway - WP2542 (Homo sapiens)
- Diclofenac metabolic pathway - WP2491 (Homo sapiens)
- TCA cycle and deficiency of pyruvate dehydrogenase complex (PDHc) - WP2453 (Homo sapiens)
- Fatty acid omega-oxidation - WP206 (Homo sapiens)
- Energy metabolism - WP1541 (Homo sapiens)
- Prostaglandin synthesis and regulation - WP995 (Bos taurus)
- Heme biosynthesis - WP967 (Bos taurus)
- Monoterpene biosynthesis pathway in mint - WP4701 (Vitis vinifera)
- Apoptosis modulation and signaling - WP3148 (Bos taurus)
- Polar auxin transport - WP2940 (Oryza sativa)
- Isoprenoid precursor biosynthesis in Pf apicoplasts - WP2918 (Plasmodium falciparum)
- Carotenoid biosynthesis - WP2205 (Zea mays)
- Ganglio sphingolipid metabolism - WP1423 (Homo sapiens)
- Glycogen metabolism - WP1073 (Bos taurus)
- Glycolysis and gluconeogenesis - WP515 (Saccharomyces cerevisiae)
- Glycogen catabolism - WP478 (Saccharomyces cerevisiae)
- Methionine degradation - WP46 (Saccharomyces cerevisiae)
- Histidine, purine, and pyrimidine superpathway - WP416 (Saccharomyces cerevisiae)
- Trehalose anabolism - WP398 (Saccharomyces cerevisiae)
- Riboflavin, FMN, and FAD biosynthesis - WP381 (Saccharomyces cerevisiae)
- Pentose pathway, non-oxidative branch - WP379 (Saccharomyces cerevisiae)
- Pentose phosphate pathway - WP369 (Saccharomyces cerevisiae)
- Threonine biosynthesis - WP331 (Saccharomyces cerevisiae)
- Phenylalanine, tyrosine, and tryptophan biosynthesis - WP27 (Saccharomyces cerevisiae)
- Starch and cellulose biosynthesis - WP257 (Saccharomyces cerevisiae)
- Phenylalanine biosynthesis - WP194 (Saccharomyces cerevisiae)
- NAD salvage pathway - WP171 (Saccharomyces cerevisiae)
- Tryptophan biosynthesis - WP165 (Saccharomyces cerevisiae)
- Homocysteine and cysteine interconversion - WP128 (Saccharomyces cerevisiae)
- Principal pathways of carbon metabolism - WP112 (Saccharomyces cerevisiae)
- UDP-glucose conversion - WP109 (Saccharomyces cerevisiae)
- MAPK signaling pathway - WP769 (Gallus gallus)
- Biosynthesis of gamma-aminobutyric acid (GABA) by polyamine oxidation - WP4232 (Arabidopsis thaliana)
- Chlorophyll b degradation - WP2230 (Arabidopsis thaliana)
- Flavonoid biosynthesis - WP1538 (Arabidopsis thaliana)
- Prostaglandin synthesis and regulation - WP98 (Homo sapiens)
- Polyol pathway - WP690 (Homo sapiens)
- TCA cycle nutrient use and invasiveness of ovarian cancer - WP2868 (Homo sapiens)
- Nicotine effect on dopaminergic neurons - WP1602 (Homo sapiens)
- Endochondral ossification - WP474 (Homo sapiens)
- DNA replication - WP466 (Homo sapiens)
- Electron transport chain: OXPHOS system in mitochondria - WP111 (Homo sapiens)
- Arachidonate epoxygenase / epoxide hydrolase - WP678 (Homo sapiens)
- Steroid biosynthesis - WP66 (Rattus norvegicus)
- Fructose metabolism in proximal tubules - WP3894 (Rattus norvegicus)
- Thick ascending limb transporters - WP3882 (Rattus norvegicus)
- Chicken limb development - WP2587 (Gallus gallus)
- Sulindac metabolic pathway - WP2541 (Rattus norvegicus)
- Non-canonical Wnt pathway - WP215 (Danio rerio)
- Glycogen metabolism - WP1388 (Danio rerio)
- Monoamine transport - WP727 (Homo sapiens)
- Calcium regulation in cardiac cells - WP536 (Homo sapiens)
- EGFR tyrosine kinase inhibitor resistance - WP4806 (Homo sapiens)
- Inflammatory response pathway - WP453 (Homo sapiens)
- Microglia pathogen phagocytosis pathway - WP3626 (Mus musculus)
- Common pathways underlying drug addiction - WP2636 (Homo sapiens)
- Biogenic amine synthesis - WP154 (Danio rerio)
- Cholesterol biosynthesis - WP103 (Mus musculus)
- Integrin-mediated cell adhesion - WP6 (Mus musculus)
- MAPK cascade - WP422 (Homo sapiens)
- p38 Mapk signaling pathway - WP350 (Mus musculus)
- ESC pluripotency pathways - WP339 (Mus musculus)
- Focal adhesion: PI3K-Akt-mTOR signaling pathway - WP2841 (Mus musculus)
- Bile acids synthesis and enterohepatic circulation - WP4389 (Homo sapiens)
- Biotic stress response gene network - WP4364 (Oryza sativa)
- Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome - WP4320 (Homo sapiens)
- Renin-angiotensin system - WP376 (Rattus norvegicus)
- Irinotecan pathway - WP229 (Homo sapiens)
- Irinotecan pathway - WP124 (Rattus norvegicus)
- Irinotecan pathway - WP1080 (Bos taurus)
- Metabolism overview - WP3602 (Homo sapiens)
- Trans-sulfuration, one-carbon metabolism and related pathways - WP2525 (Homo sapiens)
- One-carbon metabolism and related pathways - WP1770 (Mus musculus)
- TP53 network - WP1742 (Homo sapiens)
- Lactose degradation and galactose metabolism - WP546 (Saccharomyces cerevisiae)
- FGFR3 signaling in chondrocyte proliferation and terminal differentiation - WP4767 (Homo sapiens)
- Netrin-UNC5B signaling pathway - WP4747 (Homo sapiens)
- Gastrin signaling pathway - WP4659 (Homo sapiens)
- Wnt signaling - WP428 (Homo sapiens)
- PI3K/AKT/mTOR - vitamin D3 signaling - WP4141 (Homo sapiens)
- Kennedy pathway from sphingolipids - WP3933 (Homo sapiens)
- Monoamine GPCRs - WP1076 (Bos taurus)
- Histidine metabolism - WP1581 (Mycobacterium tuberculosis)
- Tamoxifen metabolism - WP691 (Homo sapiens)
- Mitochondrial fatty acid synthesis pathway - WP4317 (Homo sapiens)
- Sulfate assimilation and copper detoxification - WP4173 (Saccharomyces cerevisiae)
- Monoamine GPCRs - WP58 (Homo sapiens)
- Amyotrophic lateral sclerosis (ALS) - WP2447 (Homo sapiens)
- Phosphoinositides metabolism - WP4971 (Homo sapiens)
- Fluoroacetic acid toxicity - WP4966 (Homo sapiens)
- Pilocytic astrocytoma - WP2253 (Homo sapiens)
- RuMP cycle, oxidative branch of the pentose phosphate pathway and formaldehyde assimilation - WP332 (Saccharomyces cerevisiae)
- Type II diabetes mellitus - WP1584 (Homo sapiens)
- Amino acid conjugation of benzoic acid - WP521 (Homo sapiens)
- Genes related to primary cilium development (based on CRISPR) - WP4536 (Homo sapiens)
- Acetate mediated promotion of metabolic syndrome - WP3650 (Rattus norvegicus)
- Nanomaterial induced apoptosis - WP2507 (Homo sapiens)
- Regulation of Pgc1a expression by a Gsk3b-Tfeb signaling axis in skeletal muscle - WP4763 (Mus musculus)
- Hexoses metabolism in proximal tubules - WP3916 (Rattus norvegicus)
- Lipids measured in liver metastasis from breast cancer - WP4627 (Mus musculus)
- Overview of interferons-mediated signaling pathway - WP4558 (Homo sapiens)
- Vanillin and isovanillin metabolism - WP4501 (Rattus norvegicus)
- PI3K-AKT-mTOR signaling pathway and therapeutic opportunities - WP3844 (Homo sapiens)
- Neovascularisation processes - WP4331 (Homo sapiens)
- Cell migration and invasion through p75NTR - WP4561 (Homo sapiens)
- Control of immune tolerance by vasoactive intestinal peptide - WP4484 (Homo sapiens)
- Amino acid conjugation - WP715 (Homo sapiens)
- Glucuronidation - WP698 (Homo sapiens)
- Estrogen metabolism - WP697 (Homo sapiens)
- Oxidative phosphorylation - WP623 (Homo sapiens)
- Biomarkers for urea cycle disorders - WP4583 (Homo sapiens)
- Non-genomic actions of 1,25 dihydroxyvitamin D3 - WP4341 (Homo sapiens)
- Angiotensin II signaling (acute) in thick ascending limbs - WP3887 (Rattus norvegicus)
- Valproic acid pathway - WP3871 (Homo sapiens)
- Glutathione metabolism - WP3207 (Bos taurus)
- Dopamine metabolism - WP3155 (Bos taurus)
- Cocaine metabolism - WP2826 (Homo sapiens)
- Glucose-1-phosphate metabolism - WP260 (Saccharomyces cerevisiae)
- Glycolysis - WP253 (Saccharomyces cerevisiae)
- Dopamine metabolism - WP2436 (Homo sapiens)
- PPAR signaling pathway - WP2316 (Mus musculus)
- Oryzalexin S biosynthesis - WP2210 (Oryza sativa)
- Lycopene biosynthesis - WP2204 (Zea mays)
- Kennedy pathway - WP1771 (Mus musculus)
- Glutathione metabolism - WP100 (Homo sapiens)
- Metapathway biotransformation Phase I and II - WP702 (Homo sapiens)
- PPAR signaling pathway - WP3942 (Homo sapiens)
- G1 to S cell cycle control - WP45 (Homo sapiens)
- Caloric restriction and aging - WP4191 (Homo sapiens)
- Arylamine metabolism - WP694 (Homo sapiens)
- mRNA, protein, and metabolite inducation pathway by cyclosporin A - WP3953 (Homo sapiens)
- Lidocaine metabolism - WP3254 (Bos taurus)
- Somatroph axis (GH) and its relationship to dietary restriction and aging - WP4186 (Homo sapiens)
- Butyrate-induced histone acetylation - WP2366 (Homo sapiens)
- Regulatory circuits of the STAT3 signaling pathway - WP4538 (Homo sapiens)
- Translation inhibitors in chronically activated PDGFRA cells - WP4566 (Homo sapiens)
- Interactions between immune cells and microRNAs in tumor microenvironment - WP4559 (Homo sapiens)
- Iron uptake and transport - WP3217 (Bos taurus)
- Gluconeogenesis - WP156 (Saccharomyces cerevisiae)
- Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4) - WP2817 (Homo sapiens)
- Mammary gland development pathway - Involution (Stage 4 of 4) - WP2815 (Homo sapiens)
- Mammary gland development pathway - Puberty (Stage 2 of 4) - WP2814 (Homo sapiens)
- Mammary gland development pathway - Embryonic development (Stage 1 of 4) - WP2813 (Homo sapiens)
- Ophthalmate biosynthesis in hepatocytes - WP4487 (Homo sapiens)
- Platelet-mediated interactions with vascular and circulating cells - WP4462 (Homo sapiens)
- Phosphatidylcholine catabolism - WP4195 (Homo sapiens)
- Serotonin and anxiety - WP2141 (Mus musculus)
- Methylerythritol phosphate pathway - WP2212 (Oryza sativa)
- Mitochondrial complex I assembly model OXPHOS system - WP4324 (Homo sapiens)
- Heterochronic gene regulation of development - WP2227 (Caenorhabditis elegans)
- CRD motif and sFRPs influence on Wnt signaling - WP4231 (Danio rerio)
- Tryptophan catabolism leading to NAD+ production - WP4210 (Homo sapiens)
- Lipoic acid metabolism - WP1667 (Mycobacterium tuberculosis)
- Fructose and mannose metabolism - WP1652 (Mycobacterium tuberculosis)
- Ascorbate and aldarate metabolism - WP1622 (Mycobacterium tuberculosis)
- Heroin metabolism - WP2645 (Homo sapiens)
- SCFA and skeletal muscle substrate metabolism - WP4030 (Homo sapiens)
- Ethylene signaling pathway - WP2851 (Arabidopsis thaliana)